Market Tracker

03/29 9:05am ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

4.06
Delayed Data
As of Mar 28
 -0.11 / -2.64%
Today’s Change
1.83
Today|||52-Week Range
13.90
+109.28%
Year-to-Date
Pernix: An Investor's Rationale to Staying Long
Mar 23 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close4.17
Today’s open4.22
Day’s range3.97 - 4.50
Volume805,910
Average volume (3 months)624,447
Market cap$38.6M
Dividend yield--
Data as of 03/28/2017

Growth & Valuation

Earnings growth (last year)-198.92%
Earnings growth (this year)+41.73%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+44.44%
P/E ratioNM
Price/Sales0.89
Price/Book0.75

Competitors

 Today’s
change
Today’s
% change
THLDThreshold Pharmaceut...-0.04-7.67%
TPIVTapImmune Inc-0.20-4.38%
ANTHAnthera Pharmaceutic...+0.00+0.32%
PPHMPPeregrine Pharmaceut...+0.54+2.51%
Data as of 03/28/2017

Financials

Last reporting dateMarch 29, 2017
EPS forecast (this quarter)-$3.15
Annual revenue (last year)$175.9M
Annual profit (last year)-$148.3M
Net profit margin-84.34%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
President, Chief Financial Officer &
Director
Graham G. Miao
Corporate headquarters
Morristown, New Jersey

Forecasts